Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp. (Nasdaq: EUCR) is a blank check company sponsored by Eucrates Biomedical Holdings LLC, formed to pursue an acquisition target in the biomedical and life sciences sector. The company completed its initial public offering in 2021 and filed a Form 10-Q with the SEC on November 14, 2022, under accession number 0001410578-22-003416, reflecting its continued operation as a search-stage special purpose acquisition company. At the time of that quarterly filing, EUCR had not yet announced or completed a business combination, with management actively evaluating opportunities across the biomedical industry. For full filing history, sponsor profiles, and deal-stage analytics on EUCR, sign up for free at SpacDesk.